Cargando…
Alteration of Fatty Acid Profile in Fragile X Syndrome
Fragile X Syndrome (FXS) is the most prevalent monogenic cause of Autism Spectrum Disorders (ASDs). Despite a common genetic etiology, the affected individuals display heterogenous metabolic abnormalities including hypocholesterolemia. Although changes in the metabolism of fatty acids (FAs) have bee...
Autores principales: | Abolghasemi, Armita, Carullo, Maria Paulina, Aguilera, Ester Cisneros, Laroui, Asma, Plantefeve, Rosalie, Rojas, Daniela, Benachenhou, Serine, Ramírez, María Victoria, Proteau-Lemieux, Mélodie, Lepage, Jean-François, Corbin, François, Plourde, Mélanie, Farez, Mauricio, Cogram, Patricia, Çaku, Artuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502195/ https://www.ncbi.nlm.nih.gov/pubmed/36142726 http://dx.doi.org/10.3390/ijms231810815 |
Ejemplares similares
-
Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome
por: Laroui, Asma, et al.
Publicado: (2022) -
Association of lipid rafts cholesterol with clinical profile in fragile X syndrome
por: Toupin, Amanda, et al.
Publicado: (2022) -
Combining Lovastatin and Minocycline for the Treatment of Fragile X Syndrome: Results From the LovaMiX Clinical Trial
por: Champigny, Camille, et al.
Publicado: (2022) -
New insights of altered lipid profile in Fragile X Syndrome
por: Çaku, Artuela, et al.
Publicado: (2017) -
Attentional and executive functions in children and adolescents with developmental coordination disorder and the influence of comorbid disorders: A systematic review of the literature
por: Lachambre, Catherine, et al.
Publicado: (2021)